Cargando…
Erythropoietin therapy improves endothelial function in patients with non-dialysis chronic kidney disease and anemia (EARNEST-CKD): A clinical study
BACKGROUND: This study investigated whether administering erythropoiesis-stimulating agents (ESAs) improves endothelial function in patients with non-dialysis chronic kidney disease (CKD) and anemia. METHODS: This single-center, prospective, single-arm comparison study enrolled patients with non-dia...
Autores principales: | Lim, Jina, Yu, Chung Jo, Yu, Hoon, Ha, Sang Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542142/ https://www.ncbi.nlm.nih.gov/pubmed/34678911 http://dx.doi.org/10.1097/MD.0000000000027601 |
Ejemplares similares
-
Impact of coronary artery bypass surgery and percutaneous coronary intervention on mortality in patients with chronic kidney disease and on dialysis: A systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016) -
Earnest Rutherford, the solution
Publicado: (2003) -
Loss of nighttime blood pressure dipping as a risk factor for coronary artery calcification in nondialysis chronic kidney disease
por: Choi, Hoon Young, et al.
Publicado: (2017) -
Association of beta-2-microglobulin with cardiovascular and all-cause mortality in the general and non-CKD population
por: Fang, Hang, et al.
Publicado: (2023) -
Separate and Joint Effects of Diabetes Mellitus and Chronic Kidney Disease on the Risk of Acute Coronary Syndrome: A Population-Based Cohort Study
por: Chang, Yu-Tzu, et al.
Publicado: (2014)